January 18, 2011 — Exemestane used alone for 5 years is similar to exemestane used after 2 to 3 years of tamoxifen in the prevention of relapse in postmenopausal women with hormone-responsive early ...
Switching to exemestane after two to three years of tamoxifen treatment improved overall survival in patients with estrogen-sensitive breast cancer, according to results from the Intergroup Exemestane ...
December 14, 2009 (San Antonio, Texas) — New results coming from 2 mature trials with exemestane (Aromasin, Pfizer) suggest that this aromatase inhibitor differs slightly from the other 2 available ...
The combination of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) (palbociclib, ribociclib, abemaciclib) and endocrine therapy has become standard of care for the treatment of patients with hormone ...
A drug that scientists hoped might be a safe new way to prevent breast cancer appears to pose a risk after all: significant bone loss. The finding, published online Monday in The Lancet Oncology, ...
Review the side-effects of Exemestane as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Tamoxifen is an estrogen-receptor (ER) antagonist blocking the action of estrogen. The risk–benefit ratio of using tamoxifen for longer than 5 years in the adjuvant setting is still unclear. Aromatase ...
Postmenopausal women with primary breast cancer who were disease free after 2 to 3 years were randomly assigned to switch from tamoxifen to exemestane or continue with tamoxifen until 5 years of ...
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. If you have the appropriate software installed, you can download ...
Selective estrogen-receptor modulators (tamoxifen [Nolvadex, Soltamox], raloxifene [Evista]) have been shown to reduce the risk of breast cancer in postmenopausal women, but also have been associated ...
Tamoxifen and raloxifene have limited patient acceptance for primary prevention of breast cancer. Aromatase inhibitors prevent more contralateral breast cancers and cause fewer side effects than ...
Details concerning the Exemestane medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results